Characteristics of the study population from the cohort analysis at baseline. Values are mean ± SD or n (%). N = 1065.
| Characteristics | Values |
|---|---|
| Age, yrs | 53.7 ± 13.9 |
| Female | 470 (44.1) |
| White | 943 (88.5) |
| BMI, kg/m2 | 28.2 ± 5.6 |
| Age at PsO onset, yrs | 28.1 ± 14.5 |
| Age at PsA onset, yrs | 37 ± 13.1 |
| PASI | 5.8 ± 8.5 |
| TJC, max 68 | 6.8 ± 8.2 |
| SJC, max 66 | 3.4 ± 4.7 |
| Patients with dactylitis | 271 (25.4) |
| Patients with enthesitis | 177 (16.6) |
| ESR, mm/first h | 18.2 ± 16.3 |
| Use of systemic corticosteroids | 89 (8.4) |
| Cumulative corticosteroid dose* | 0.37 ± 2.83 |
| Use of DMARD | 478 (44.9) |
| Use of biologic medications | 68 (6.4) |
↵* Equivalent to prednisone in grams. BMI: body mass index; PsO: psoriasis; PsA: psoriatic arthritis; PASI: Psoriasis Area and Severity Index; TJC: tender joint count; SJC: swollen joint count; ESR: erythrocyte sedimentation rate; DMARD: disease-modifying antirheumatic drugs.